Form 4: Amedisys EVP, CFO & COO Scott Ginn Reports Acquisition of 17,495 Shares of Common Stock

Scott Ginn, EVP, CFO & COO of Amedisys Inc., reports acquiring 17,495 shares of common stock through time-based RSUs and disposing of 1,795 shares to cover tax obligations.

Summary

• On February 16, 2025, Scott Ginn, the EVP, CFO & COO of Amedisys Inc., acquired 17,495 shares of common stock through time-based Restricted Stock Units (RSUs).
• These RSUs will vest 25% on each of February 16, 2026, and February 16, 2027, and 50% on February 16, 2028, contingent upon continuous employment with the Issuer.
• On the same day, Ginn disposed of 1,795 shares of common stock at a price of $92.6 to satisfy tax obligations.
• Following these transactions, Ginn directly owns 96,486 shares and indirectly owns 2,714 shares through a 401(k) plan, based on a plan statement dated December 31, 2024.
• The total amount of shares beneficially owned includes 887 shares held in an employee stock purchase plan account.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The acquisition of shares is a positive sign, but the disposal for tax obligations is a standard procedure.

Positives

• The acquisition of 17,495 shares through RSUs indicates confidence in the company's future performance by a key executive.
• The vesting schedule incentivizes long-term commitment from the EVP, CFO & COO.

Negatives

• The disposal of 1,795 shares, while for tax obligations, could be perceived negatively, although it's a common practice.

Risks

• The vesting of RSUs is contingent upon continuous employment, creating a potential risk if the executive leaves the company before the vesting dates.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedule of the RSUs suggests an expectation of continued employment and company performance.

Industry Context

Executive stock ownership is a common practice in publicly traded companies to align management's interests with those of shareholders. RSU grants are a typical component of executive compensation packages.

Comparison to Industry Standards

• Comparing Amedisys' executive compensation structure with that of its competitors like LHC Group (now part of Optum), Encompass Health, and Brookdale Senior Living would provide a more comprehensive understanding of whether the RSU grants are in line with industry norms.
• Benchmarking the vesting schedule and the number of shares granted to executives in similar roles at these companies would be relevant.
• For example, LHC Group's executive compensation packages often include a mix of salary, stock options, and RSUs, with vesting schedules tied to performance metrics and continued employment.
• Encompass Health also uses a combination of equity-based incentives to retain and motivate its leadership team.

Stakeholder Impact

• The stock transactions by a key executive could influence investor sentiment, although the impact is likely to be minimal given the routine nature of the filing.
• Employees may view the RSU grants as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Amedisys, Scott Ginn, RSUs, Stock Acquisition, Form 4, Beneficial Ownership, Executive Compensation, AMED